RecruitingNCT05146336

CytOSorb TreatMent Of Critically Ill PatientS Registry

CytOSorb TreatMent Of Critically Ill PatientS Registry: International Registry on the Use of CytoSorb in the Critical Care Setting

Sponsor

CytoSorbents, Inc

Enrollment

3,000 participants

Start Date

Jun 22, 2022

Study Type

OBSERVATIONAL

Conditions

Sepsis Liver Transplant; Complications Pancreatitis Acute-On-Chronic Liver Failure Cardiogenic Shock Septic Shock Trauma Hemophagocytic Lymphohistiocytoses Acute Respiratory Distress Syndrome Rhabdomyolysis Acute Liver Failure Burns Extracorporeal Life Support Infectious Disease Drug Overdose Chimeric Antigen Receptor T-Cell Therapy (CAR-T) Cytokine Release Syndrome (CRS)Postoperative Endocarditis Postoperative Vasoplegic Syndrome

Summary

Registry intended to provide a data repository and reporting infrastructure for the surveillance of CytoSorb device use in real-world critical care settings, and to serve as an objective, comprehensive, and scientifically-based resource to measure and improve the quality of patient care

Eligibility

Plain Language Summary

Simplified for easier understanding

This is an observational registry study tracking patients in intensive care who are receiving treatment with a blood purification device called CytoSorb. The device filters harmful inflammatory molecules from the blood in critically ill patients. This study collects real-world data on how well it works and how safe it is. **You may be eligible if...** - You are a critically ill patient who is receiving (or planned to receive) treatment with the CytoSorb 300 mL device - You or your representative can provide informed consent **You may NOT be eligible if...** - The device is only being used to remove blood thinners (antithrombotic agents), not for other critical illness treatment - The device is only being used during heart surgery in the operating room - A medical complication arises that makes using the device no longer appropriate after consent is obtained Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICECytoSorb

Sorbent hemoperfusion system

Locations(28)

Klinikum Klagenfurt am Wörthersee

Klagenfurt, Austria

Medizinische Universität Wien

Vienna, Austria

Universitätsklinikum Aachen

Aachen, Germany

Herz- und Diabeteszentrum Nordrhein-Westfalen

Bad Oeynhausen, Germany

Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil Bochum

Bochum, Germany

Katholisches Klinikum Bochum, St. Josef-Hospital

Bochum, Germany

Universitätsklinikum Essen, Medizinische Intensivtherapie

Essen, Germany

Universitätsklinikum Essen, Nephrologie

Essen, Germany

Universitätsklinikum Essen, Thorax- und Kardiovaskuläre Chirurgie

Essen, Germany

Universitätsmedizin Göttingen, Allgemein-, Viszeral- und Kinderchirurgie

Göttingen, Germany

Universitätsmedizin Göttingen, Herzzentrum Göttingen

Göttingen, Germany

Klinikum Herford

Herford, Germany

Universitätsklinikum Jena

Jena, Germany

Klinikum Kassel

Kassel, Germany

Universitätsklinikum Marburg

Marburg, Germany

Kliniken Maria Hilf

Mönchengladbach, Germany

Deutsches Herzzentrum München

München, Germany

LMU Klinikum München

München, Germany

Klinikum Oldenburg

Oldenburg, Germany

Helios Dr. Horst Schmidt Kliniken Wiesbaden

Wiesbaden, Germany

Ospedale Pediatrico Bambino Gesù

Roma, Italy

IRCCS Ospedale Casa Sollievo della Sofferenza

San Giovanni Rotondo, Italy

SP ZOZ Szpital Uniwersytecki w Krakowie

Krakow, Poland

Uniwersyteckim Spitalem Klinicznym im. Jana Mikulicza - Radeckiego we Wrocławiu

Wroclaw, Poland

Unidade Local de Saúde de Coimbra E.P.E

Coimbra, Portugal

ULS São José, Hospital Curry Cabral

Lisbon, Portugal

Hospital Universitari Vall d'Hebron

Barcelona, Barcelona, Spain

Hospital Juan Ramón Jimenez

Huelva, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05146336

Related Trials

UMMS Sepsis Early Prediction Score (SEPSys) and RESCUE Score Combined Clinical Trial

NCT067796178 locations

Onyx™ Liquid Embolic IDE Clinical Study

NCT0674280116 locations

A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.

NCT0721570271 locations

Transcatheter Mitral Valve Repair for Inotrope Dependent Cardiogenic Shock

NCT052981244 locations

Veno-arterial Carbon Dioxide Partial Pressure Difference (CO2gap) for Early Resuscitation of Septic Shock

NCT0717927627 locations